HTA Database - Search Results

Sort by Relevance

Search Results [916 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer]
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[P16/Ki-67 dual stain in the triage of PAPIII/IIID cytology in cervical cancer screening]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prostate cancer screening: a review of the guidelines
2013	HAYES, Inc.	Photoscreening for the detection of amblyopia risk factors in children
2013	NIHR Health Technology Assessment programme	AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal screening procedures prior to physician visits: guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Advisability of expanding the Québec newborn blood screening program]
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: national population screening programme for bowel cancer
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for sexually transmitted infections: a review of guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013	NIHR Health Technology Assessment programme	Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test]
2013	NIHR Health Technology Assessment programme	Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Reorientation of the Austrian parent-child preventive care programme - Part IX: Evidence-based screening guidelines for pregnant women and children (0 – 6 yrs.)]
2013	HAYES, Inc.	Low-dose helical (spiral) computed tomography for lung cancer screening
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for classical galactosemia]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for tyrosemia type I]
2013	NIHR Health Technology Assessment programme	Systematic review of the psychological consequences of false-positive screening mammograms
2012	Andalusian Health Technology Assessment Area (AETSA)	[Rapid tests for methicillin resistant Staphylococcus aureus. Carrier screening. Executive summary]
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[Combined screening for early diagnosis of chromosomal abnormalities during the first trimester of pregnancy]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A research on evidence-based healthcare for thyroid cancer screening: Part 1: the current status of thyroid cancer screening]
2012	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of genetic tests for screening of colorectal cancer]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Validation of a malnutrition screening tool useful in a general hospital]
2012	Health Information and Quality Authority (HIQA)	Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012	NIHR Horizon Scanning Centre (NIHR HSC)	HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening
2012	NIHR Health Technology Assessment programme	Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for glaucoma: comparative effectiveness
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for use of screening and preventive services
2012	Health Sciences Institute in Aragon (IACS)	Programme activities for early detection of health problems between 0 and 14 years old. Effectiveness, safety and economic evaluation of the different alternatives in the early detection of hip dysplasia in newborns
2012	NIHR Health Technology Assessment programme	Screening for cystic fibrosis-related diabetes: a systematic review
2012	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012	HAYES, Inc.	Screening, brief intervention, and referral to treatment (SBIRT) for substance use among pregnant women
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening and diagnosing gestational diabetes mellitus
2012	Agency for Healthcare Research and Quality (AHRQ)	An evidence review of active surveillance in men with localized prostate cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012	Institute of Health Economics (IHE)	The effectiveness and safety of preschool hearing screening programs
2012	Institute of Health Economics (IHE)	The safety and effectiveness of preschool vision screening
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Implementation of screening and treatment of high-risk fracture patients by an osteoporosis nurse-practitioner]
2012	Institute of Health Economics (IHE)	The safety and efficacy/effectiveness of using automated testing devices for universal newborn hearing screening: an update
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for HIV: systematic review to update the U.S. Preventive Services Task Force Recommendation
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012	Agency for Healthcare Research and Quality (AHRQ)	Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[HIV screening in the general population]
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for colorectal cancer part 1: screening-tests and program design
2012	Andalusian Health Technology Assessment Area (AETSA)	[Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2012	Belgian Health Care Knowledge Centre (KCE)	Hepatitis C screening and prevention
2012	Canary Health Service	[Cost-effectiveness of expanded newborn screening by mass spectrometry]
2012	Canary Health Service	[Cost-effectiveness of newborn screening for cystic fibrosis]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Benefit assessment of HPV testing in primary screening for cervical cancer]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Nurse-endoscopy of the colon; a randomized trial on accuracy, patient experiences and costs]
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2011	NIHR Health Technology Assessment programme	MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
2011	Health Council of the Netherlands Gezondheidsraad (GR)	Population screening act: prostate cancer screening using MRI
2011	Agency for Healthcare Research and Quality (AHRQ)	Screening for hearing loss in adults ages 50 years and older: a review of the evidence for the U.S. Preventive Services Task Force.
2011	Agency for Healthcare Research and Quality (AHRQ)	Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2011	HAYES, Inc.	Rapid antibody tests for HIV screening
2011	Haute Autorite de sante (HAS)	[A priori evaluation of the expansion of newborn screening to one or more inborn error(s) of metabolism using the technology of tandem mass spectrometry in the general population in France. Part 1: medium chain CoA dehydrogenase deficiency (MCADD)]
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Brief screening tests for depression in emergency patients
2011	Agency for Healthcare Research and Quality (AHRQ)	Update on horizon scans of genetic tests currently available for clinical use in cancers
2011	Health Intervention and Technology Assessment Program (HITAP)	[Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2011	Health Intervention and Technology Assessment Program (HITAP)	[School-based screening for Attention Deficit and Hyperactivity Disorder (ADHD) and Learning Disorders (LD)]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Over-, under- and misuse of pain treatment in Germany]
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Prostate cancer screening
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Nasopharyngeal carcinoma screening
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	HPV DNA-based screening test for cervical cancer
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	Pulse oximetry (POX) screening for congenital heart defects in newborns
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fact sheet: Screening for gestational diabetes - rapid report]
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of HPV test in primary screening for cervical cancer]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Vision screening of preschool children]
2010	Health Council of the Netherlands Gezondheidsraad (GR)	[Prenatal screening for trisomy 13 and 18]
2010	HAYES, Inc.	Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2010	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2010	Medical Advisory Secretariat (MAS)	Clinical utility of vitamin D testing: an evidence-based analysis
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Autism spectrum disorder: scientific knowledge about the detection, diagnosis and treatment]